Anifrolumab Shows Promise in Refractory Discoid Lupus Anifrolumab Shows Promise in Refractory Discoid Lupus

The study evaluated the records of eight women with DLE recalcitrant to standard therapies who were treated with anifrolumab for at least 8 weeks.MDedge News
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Dermatology News Source Type: news